A.R.T. Advisors’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-6,000
| Closed | -$917K | – | 262 |
|
|
2019
Q4 | $917K | Buy |
+6,000
| New | +$917K | 0.05% | 595 |
|
|
2019
Q1 | – | Sell |
-12,600
| Closed | -$1.43M | – | 1356 |
|
|
2018
Q4 | $1.43M | Buy |
+12,600
| New | +$1.43M | 0.09% | 327 |
|
|
2017
Q4 | – | Sell |
-10,000
| Closed | -$1.08M | – | 1419 |
|
|
2017
Q3 | $1.08M | Buy |
+10,000
| New | +$1.08M | 0.06% | 498 |
|
|
2017
Q2 | – | Sell |
-6,900
| Closed | -$620K | – | 1462 |
|
|
2017
Q1 | $620K | Sell |
6,900
-2,000
| -22% | -$180K | 0.03% | 733 |
|
|
2016
Q4 | $678K | Buy |
+8,900
| New | +$678K | 0.04% | 622 |
|
|
2016
Q3 | – | Sell |
-36,114
| Closed | -$2.98M | – | 745 |
|
|
2016
Q2 | $2.98M | Buy |
36,114
+1,400
| +4% | +$115K | 0.15% | 193 |
|
|
2016
Q1 | $2.64M | Buy |
34,714
+12,500
| +56% | +$949K | 0.12% | 241 |
|
|
2015
Q4 | $1.79M | Buy |
22,214
+16,700
| +303% | +$1.34M | 0.08% | 332 |
|
|
2015
Q3 | $350K | Buy |
+5,514
| New | +$350K | 0.01% | 992 |
|
|
2014
Q4 | – | Sell |
-9,115
| Closed | -$544K | – | 1450 |
|
|
2014
Q3 | $544K | Sell |
9,115
-25,835
| -74% | -$1.54M | 0.03% | 713 |
|
|
2014
Q2 | $1.87M | Buy |
34,950
+11,630
| +50% | +$622K | 0.1% | 300 |
|
|
2014
Q1 | $1.41M | Buy |
23,320
+16,410
| +237% | +$990K | 0.07% | 368 |
|
|
2013
Q4 | $366K | Buy |
6,910
+821
| +13% | +$43.5K | 0.02% | 904 |
|
|
2013
Q3 | $281K | Sell |
6,089
-47,118
| -89% | -$2.17M | 0.02% | 1001 |
|
|
2013
Q2 | $2.18M | Buy |
+53,207
| New | +$2.18M | 0.07% | 382 |
|